Treatment of Drug Dependence: What Works

References

• Kleber H. D. Treatment of narcotic addicts. Psychiatric Medicine 1987; 3: 389–418
   Google Scholar
• McLellan A. T. The psychiatrically severe drug abuse patient: Methadone maintenance or therapeutic community?. American Journal of Drug & Alcohol Abuse 1984; 10: 77–95
   PubMed Web of Science ®Google Scholar
• Cohen S. Rehabilitation of the addicted. Drug Abuse and Alcoholism Newsletter 1977; 6: 1–3
   Google Scholar
• Maddux J. F., Desmond D. P. Residence relocation inhibits opioid dependence. Archives of General Psychiatry 1982; 39: 1313–1317
   PubMed Web of Science ®Google Scholar
• The Family Therapy of Drug Abuse and Addiction, M. D. Stanton, T. Todd, et al. Guilford Press, New York 1982
   Google Scholar
• Anton R. F., Hogan I., Jalai B., et al. Multiple family therapy and naltrexone in the treatment of opiate dependence. Drug and Alcohol Dependence 1981; 8: 157–168
   PubMed Web of Science ®Google Scholar
• Rounsaville B. J., Weissman M. M., Kleber H. D. An evaluation of depression in opiate addicts. Research in Community and Mental Health 1983; 3: 257–289
   Google Scholar
• Kleber H. D., Weissman M. M., Rounsaville B. J. Imipramine as treatment for depression in addicts. Archives of General Psychiatry 1983; 40: 649–653
   PubMed Web of Science ®Google Scholar
• Kleber H. D. Concomitant use of methadone with other psychoactive drugs in the treatment of opiate addicts with other DSM-III diagnoses. NIDA Research Monograph, Research on the Treatment of Narcotic Addiction. DHSS Publication (ADM) 83–1281, NIDA, Rockville, MD 1983
   Google Scholar
• Moffett A. D., Soloway I. H., Glick M. X. Post-treatment behavior following ambulatory detoxification. Methadone-Experience and Issues, C. D. Chambers, L. Brill. Behavioral Publications, New York 1973; 215–227
   Google Scholar
• Sheffet A., Quinones M., Lavenhar M. A., et al. An evaluation of detoxification as an initial step in the treatment of heroin addiction. American Journal of Psychiatry 1976; 133–337
   Google Scholar
• Kleber H. D., Riordan C. E. The treatment of narcotic withdrawal: a historical review. Journal of Clinical Psychiatry 1982; 43: 30–34, Section 2
   PubMed Web of Science ®Google Scholar
• Kleber H. D. Drag dependence. Psychiatry in the Practice of Medicine, chapter 16, H. Leigh. Addison-Wesley, Menlo Park, CA 1983
   Google Scholar
• Gold M. S., Pottash A. L. C., Sweeney D. R., et al. Rapid opiate detoxification: clinical evidence of antidepressant and antipanic effects of opiates. American Journal of Psychiatry 1979; 136–982
   Google Scholar
• Gold M. S., Pottash A. L. C., Sweeney D. R., et al. Opiate withdrawal using clonidine: a safe, effective and rapid nonopiate treatment. Journal of American Medical Association 1980; 243: 343–346
   PubMed Web of Science ®Google Scholar
• Kleber H. D., Topazian M., Gaspari J., et al. Clonidine and Naltrexone in the outpatient treatment of heroin withdrawal. American Journal of Drug & Alcohol Abuse 1987; 13: 1–17
   PubMed Web of Science ®Google Scholar
• Vining E., Kosten T. R., Kleber H. D. Clinical utility of rapid clonidine-naltrexone detoxification for opioid abusers. British Journal of Addiction 1988; 83: 567–575
   PubMedGoogle Scholar
• Wen H. L., Cheung S. Y. C. Treatment of drug addiction by acupuncture and electrical stimulation. American Journal of Acupuncture 1973; 1: 71
   Google Scholar
• Whitehead P. C. Acupuncture in the treatment of addiction: a review and analysis. International Journal of the Addictions 1978; 13: 1
   PubMed Web of Science ®Google Scholar
• Gossop M., et al. The clinical effectiveness of electrostimulation vs oral methadone in managing opiate withdrawal. British Journal of Psychiatry 1984; 144: 203–208
   PubMed Web of Science ®Google Scholar
• Dole V. P., Nyswander M. A. Medical treatment of diacetylmorphine (heroin) addiction. Journal of American Medical Association 1965; 193: 646
   PubMed Web of Science ®Google Scholar
• Hargreaves W. A. Methadone dosage and duration for maintenance treatment. NIDA Treatment Research Monograph, Research on the Treatment of Narcotic Addiction. DHSS Publication (ADM) 83–1281, NIDA, Rockville, MD 1983
   Google Scholar
• Senay E. C., Dorus W., Goldberg F., et al. Withdrawal from methadone maintenance. Archives of General Psychiatry 1977; 34: 361–367
   PubMed Web of Science ®Google Scholar
• Kleber H. D., Riordan C. E., Rounsaville B. J., et al. Clonidine in outpatient detoxification from methadone maintenance. Archives of General Psychiatry 1985; 42: 391–394
   PubMed Web of Science ®Google Scholar
• Novick D. M., et al. Methadone maintenance patients in general medical practice. Journal of American Medical Association 1988; 259: 3299–3302
   PubMed Web of Science ®Google Scholar
• Kreek M. J. Health consequences associated with the use of methadone. NIDA Treatment Research Monograph, Research on the Treatment of Narcotic Addiction. DHSS Publication (ADM) 83–1281, NIDA, Rockville, MD 1983
   Google Scholar
• Carroll J. F. X., Malloy T. E., Kenrick F. M. Alcohol abuse by drug-dependent persons: A literature review and evaluation. American Journal of Drug & Alcohol Abuse 1977; 4: 293–315
   PubMed Web of Science ®Google Scholar
• Kleber H. D. Naltrexone. Journal of Substance Abuse Treatment 1985; 2: 117–122
   PubMedGoogle Scholar
• Kleber H. D., Kosten T. R. Naltrexone induction: Psychologic and pharmacologic strategies. Journal of Clinical Psychiatry 1984; 45: 29–38
   PubMed Web of Science ®Google Scholar
• Mirin S. M., Meyer R. F., McNamee H. B., et al. Psychopathology, craving and mood druing heroin acquisition: An experimental study. International Journal of Addictions 1976; 11: 525
   PubMed Web of Science ®Google Scholar
• Washton A. M., Gold M. F., Pottash A. C. Successful use of Naltrexone in addicted physicians and business executives. Advances in Alcohol and Substance Abuse 1984; 4: 89–96
   PubMedGoogle Scholar
• Brahen L. S., Capone T. J., Capone D. M. Naltrexone: Lack of effect on hepatic enzymes. Journal of Clinical Pharmacology 1988; 28: 64–70
   PubMedGoogle Scholar
• Kleber H. D., et al. Nontolerance to the opioid antagonism of Naltrexone. Biological Psychiatry 1985; 20: 66–72
   PubMed Web of Science ®Google Scholar
• Mello N. K., Bree M. P., Mendelson J. H. Comparison of buprenorphine and methadone effects on opiate self-administration in primates. Journal of Pharmacology and Experimental Therapeutics 1983; 225: 378–386
   PubMed Web of Science ®Google Scholar
• Kosten T. R., Kleber H. D. Buprenorphine detoxification from opioid dependence—a pilot study. Life Science 1988; 42: 635–641
   PubMed Web of Science ®Google Scholar
• Deitch D. A., Zweben J. E. A pioneering response in drug abuse treatment and a signal for caution. Substance Abuse: Clinical Problems and Perspectives, J. H. Lowinson, P. Ruiz. Waverly Press, Inc, Baltimore, MD 1981
   Google Scholar
• DeLeon G., Wexler H., Jainchill N. The therapeutic community: success and improvement rates 5 years after treatment. International Journal of Addictions 1982; 17: 703–747
   PubMedGoogle Scholar
• Kleber H. D., Slobetz F. Outpatient drug free treatment. NIDA Handbook on Drug Abuse. U.S. Government Printing Office, Washington, DC 1979
   Google Scholar
• Joe G. W., Singh B. K., Garland J., et al. Retention in outpatient drug-free treatment clinics. Addictive Behavior 1983; 8: 219–234
   PubMedGoogle Scholar
• Stitzer M. L., Bigelow G. E., McCaul M. E. Behavioral approaches to drug abuse. Progress in Behavior Modification 1983; 14: 49–124
   Google Scholar
• Jaffe J. H. Multimodality approaches to the treatment and prevention of opiate addiction. Opiate Addiction: Origins and Treatment, S. Fisher, A. M. Freedman. Winston and Sons, Washington 1973
   Google Scholar
• Kleber H. D. The Drug Dependence Unit of the Connecticut Mental Health Center. Organization and Administration of Drug Abuse Treatment Programs, J. G. Cull, E. E. Hardy. Charles Thomas, Springfield, IL 1974; 51–60
   Google Scholar
• Glasscote R., Sussex J., Jaffe J., et al. The treatment of drug abuse: Programs, problems, prospects. The Joint Information Service of the American Psychiatric Association and the National Association for Mental Health, Washington, DC, 1972
   Google Scholar
• Hess C. B. A seven year follow-up study of 156 males in a religious therapeutic community. Critical Concerns in the Field of Drug Abuse, A. Shechter, H. Alkesne, E. Kaufman. Marcel Dekker, New York 1977
   Google Scholar
• Fischman M. W., Schuster C. R., Javaid J. I., et al. Acute tolerance development to the cardiovascular and subjective effects of cocaine. Journal of Pharmacology and Experimental Therapeutics 1985; 235: 677–682
   PubMed Web of Science ®Google Scholar
• Gawin F. H., Kleber H. D. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Archives of General Psychiatry 1986; 43: 107–113
   PubMed Web of Science ®Google Scholar
• Gawin F. H., Kleber H. D. Cocaine abuse treatment: an open pilot trial with Desipramine and Lithium. Archives of General Psychiatry 1984; 41: 903–909
   PubMed Web of Science ®Google Scholar
• Gawin F. H. New uses of antidepressants in cocaine abuse. Psychosomatics 1986; 27: 27–29, Suppl.
   Google Scholar
• Gawin F. H., Kleber H. D., Byck R., et al. Desipramine facilitation of initial cocaine abstinence. Archives of General Psychiatry 1989; 46: 117–121
   PubMed Web of Science ®Google Scholar
• Tenant F. S., Jr., Sagherian A. A. Doubleblind comparison of amantadine and bromocriptine for ambulatory withdrawal for cocaine dependence. Archives of internal Medicine 1987; 147: 109–112
   PubMedGoogle Scholar
• Dackis C., Gold M. S., Sweeney D., et al. Single dose bromocriptine reverses cocaine craving. Psychiatry Research 1987; 20: 261–264
   PubMed Web of Science ®Google Scholar
• Gawin F. H., Riordan C. E., Kleber H. D. Methylphenidate treatment of cocaine abusers without attention deficit disorder: A negative report. American Journal of Drug & Alcohol Abuse 1985; 2: 193–197
   Google Scholar
• Khantzian E. H., Gawin F. H., Riordan C., et al. Methylphenidate treatment of cocaine dependence: a preliminary report. Journal of Substances Abuse Treatment 1984; 1: 107–112
   PubMedGoogle Scholar
• Gold M. S., Pottash A. L. C., Annitto W. D., et al (1983) Cocaine withdrawal: efficacy of tyrosine. 13th Annual Meeting of the Society of Neuroscience, Boston, November, 71983
   Google Scholar
• Anker A. L., Crowley T. J. Use of contingency contracting in specialty clinics for cocaine abuse. Problems of Drug Dependence 1981, L. S. Harris. NIDA Research Monograph, No. 41, U.S. Government Printing Office, Washington, DC 1982; 452–459
   Google Scholar
• Siegel R. K. Treatment of cocaine abuse: historical and contemporary perspectives. Journal of Psychoactive Drugs 1985; 171: 1–9
   Google Scholar
• Rounsaville B. J., Gawin F. H., Kleber H. D. Interpersonal Psychotherapy adapted with ambulatory cocaine abusers. American Journal of Drug and Alcohol Abuse 1985; 11: 171–191
   PubMed Web of Science ®Google Scholar
• Carroll K. M., Keller D. S., Fenton L. R., Gawin F. Psychotherapy for cocaine abusers. The Cocaine Crisis, D. Allen. Plenum Press, New York 1987
   Google Scholar
• Marlatt G. A., Gordon J. R. Determinants of relapse: implications for the maintenance of behavior change. Behavioral Medicine: changing health lifestyles, P. O. Davidson, S. M. Davidson. Brunner/Mazel, New York 1980; 410–452
   Google Scholar
• Kleber H. D. Epidemic Cocaine Abuse: America's present, Britain's future?. British Journal of Addiction 1988; 83: 1359–1371
   PubMedGoogle Scholar
• Roffman R. A., Stephens R. S., Simpson E. E., Whitaker D. L. Treatment of marijuana dependence: preliminary results. Journal of Psychoactive Drugs 1988; 20: 129–137
   PubMed Web of Science ®Google Scholar
• Strassman R. J. Adverse reactions to psychedelic drugs: a review of the literature. Journal of Nervous and Mental Disease 1984; 172: 577–595
   PubMed Web of Science ®Google Scholar
• Kosten T. R., Kleber H. D. Psychoactive substance use Disorders: drug abuse. Outpatient Psychiatry—Diagnosis and Treatment2nd Edn, A. Lazare. Williams & Wilkins, Baltimore 1989; 488–509
   Google Scholar